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Abstract
Background: The first-ever round of school-based mass drug administration (MDA) with praziquantel together
with mebendazole targeting school-aged children in endemic districts was conducted in 2009 by the National
Neglected Tropical Diseases Control Program. To evaluate the impact of the treatment regimen, a cross-sectional
sentinel site survey was conducted 6 months post-MDA.
Methods: Fifteen sentinel schools from six highly endemic districts (according to data from national and pre-MDA
surveys) with Schistosoma mansoni affecting over 50% of the population, and moderate to high prevalence of
hookworms (> 20%). Approximately 30 children aged 9-14 years were selected from each school and stool samples
(one per student) were examined by the Kato-Katz method.
Results: The overall prevalence (and intensity) in these sentinel sites pre-MDA of S. mansoni was 69.0% (170.8 epg),
hookworm: 41.7% (71.7 epg), Ascaris lumbricoides: 1.8% and Trichuris trichiura: 3.8%. Six months post MDA, the
findings were S. mansoni: 38.2% (47.3 epg) and hookworm: 14.5% (8.7 epg), representing a reduction from pre-
MDA levels of 44.6% (65.2%) and 72.3% (87.9%) respectively. The proportion of children who were moderately or
heavily infected with S. mansoni fell from 35.6% pre MDA to 9.9% post MDA.
Conclusions: Significant reduction in S. mansoni and hookworm infection was achieved by this first round MDA in
school-going children in Sierra Leone. This reduction in infection burden can potentially contribute to a reduction
of morbidity, such as anaemia, in these children.
Background
Schistosomiasis and soil-transmitted helminthiasis (STH)
inflict a significant health and socioeconomic burden in
the tropics and subtropics particularly in sub-Saharan
Africa [1-3]. It is estimated that over 200 million people
are infected with schistosomes worldwide and about two
billion with STHs [2,3]. Combined, schistosomiasis and
STHs cause loss of 44 million or more disability adjusted
life years (DALYs) each year, more than those due to
malaria: 36 million and approaching due to tuberculosis:
47 million [4-6]. Schistosomiasis alone could be
responsible for 200,000 deaths annually in sub-Saharan
Africa, and STH responsible for 135,000 deaths per year
globally [7].
Worm infections in children can result in stunting, wast-
ing, diminished physical fitness, impaired memory and
cognition [5,8] which combine to reduce educational per-
formance, school attendance, future adult productivity,
wage-earning capacity [5,9] and thus Gross National Pro-
ductivity. These infections also have direct and indirect
effects on malaria and HIV/AIDS in developing countries
where they are co-endemic [10].
Sierra Leone is a country on the Atlantic coast in wes-
tern Africa with a total population of about 6 million, of
which approximately 25% are school-age children. Both
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ern parts of the country [11], and S. mansoni is the main
species with focal prevalence of up to 95% [12-14].
National mapping and supplementary mapping of
S. mansoni and STHs was conducted in 2008 and 2009
and spatial analysis predicted that S. mansoni was highly
prevalent in the northeast [15,16]. Data on STH preva-
lence from the 1990s showed the national endemicity
with ranges in school aged children for hookworm:
25-43%, A.lumbricoides: 32-93% and T. trichiura:3 9 - 7 5 %
[17-22].
Annual MDA for STH commenced in some primary
schools from 2004, biannual MDA in pre-school children
from 2006 and annual MDA in the lymphatic filariasis
elimination program from 2008.
The World Bank listed regular de-worming of children
as one of the most cost-effective health interventions a
developing nation can undertake and the World Health
Assembly Resolution 54:9 encouraged member states to
reach at least 75% of school aged children with regular
annual de-worming in moderate-high transmission zones
by 2010. In Sierra Leone, an integrated national control
program on the neglected tropical diseases started in 2008
with financial support from the United States Agency for
International Development and technical assistance from
Helen Keller International. Following the disease mapping
described above, a school-based MDA with praziquantel
for schistosomiasis was performed for the first time in
June 2009 in districts moderately-highly endemic for
S. mansoni and mebendazole was also included in the dis-
tribution for STH. No schistosomiasis control activities
had taken place prior to this first round of MDA in 2009.
T h i ss t u d yr e p o r t st h ep r e v a l e n c ea n di n t e n s i t yo f
S. masoni and STH in school children 9-14 years of age
in these endemic sentinel sites 6 months after treatment
with praziquantel and mebendazole and compares these
with the pre-MDA levels. The paper reports on the pro-
tocols put in place prior to MDA to alleviate potential
side effects and the additional costs these represent to
the program.
Methods
National control program
A National Neglected Tropical Disease Control Program
(NTDCP) was established in Sierra Leone by the Ministry
of Health and Sanitation in 2008 to target onchocerciasis,
lymphatic filariasis, schistosomiasis, STH and trachoma. It
was based upon the existing Community Directed Treat-
ment with Ivermectin (CDTI) platform developed for
onchocerciasis control [23]. As part of the integrated effort
for NTD control, national mapping of schistosomaisis and
STH was conducted in 2008 [15] and a complementary
survey in 6 highly endemic districts in 2009 [16]. Follow-
ing the mapping, MDA activities were planned by the
NTDCP. Considering the high prevalence of schistosomia-
sis in many districts and the first ever large-scale prazi-
quantel distribution in the country, the MDA was started
in a carefully planned, phased manner. The first phase tar-
geted only school-going children in all primary schools in
six highly or moderately endemic districts in June 2009
through school-based drug delivery. To minimize the side-
effects of praziquantel treatment in this first-ever MDA, a
special school feeding program for children to be treated
was arranged with the support of USAID, as in rural set-
tings in Sierra Leone, many children go to school in the
morning without a meal and some may not have eaten the
night before. The health workers were trained not to give
praziquantel to any child with a history of convulsions
during MDA. Supplies of anti-histamines and paracetamol
were donated to the NTDCP by the St Andrews Clinic for
Children-SL a local NGO, for distribution by health staff
to children if any mild side-effects might occur. A total of
562,980 school children were treated with praziquantel
and 549,701 were also treated with mebendazole with
reported coverage of 94% and 92% respectively in this first
round of MDA [23].
Study site selection and data collection
From the mapping in 2008 and the complementary survey
in 2009, fifteen (15) schools shown to have high preva-
lence of schistosomaisis (≥ 50%) and moderate or high
prevalence of hookworm (≥ 20%) were selected as sentinel
sites from Bo (Southern Province), Kailahun, Kenema and
Kono (Eastern Province), Tonkolili and Koinadugu
(Northern Province). Data collection for pre-MDA was
already described previously [15,16]. Briefly, a single stool
sample was collected from each participant and one slide
per sample was prepared and examined using the Kato-
Katz method by experienced examiners.
Six months after the treatment with praziquantel and
mebendazole a cross-sectional survey was conducted in
the selected sentinel schools. After sensitization of the
community and school teachers approximately 30 chil-
dren aged 9-14 years were randomly sampled in each
site without discrimination by gender, religion or ethni-
city. A single stool sample was collected from each par-
ticipant, labelled and preserved in 10% formalin as did
previously [16]. Participants were given albendazole 400
mg after the collection of specimens. The samples were
transported back and later examined in the Njala Uni-
versity laboratory using the Kato-Katz method using a
41.7 um template (Vestergard Asia, PVT Ltd, India).
One slide per sample was prepared and examined by
experienced examiners. S. mansoni and STH eggs were
counted and intensity of individual infections were cal-
culated and expressed as eggs per gram of faeces (epg).
Infections in children were classified as low, moderate
or heavy infections according to the intensity of
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classifications [24].
Data analysis
Results obtained were entered into Epi info
® version 3.5.1
and exported into SPSS 19.0 for analysis. For data from
the surveys before MDA only those children aged 9-14
years were included in the current analysis. Analysis was
done using SPSS Complex Samples (districts as strata and
schools as clusters). Samples in each school were weighted
according to the standard sample size (30). Chi square test
w a su s e dt oc o m p a r et h ep r e v a l e n c eb e f o r ea n da f t e r
MDA. Kruskal Wallis test was used to compare the inten-
sity of infection before and after MDA. The 95% confi-
dence intervals (CIs) for prevalence were calculated using
the Wilson score method without continuity correction
after adjusting for sample weighting [25]. GPS coordinates
were recorded and ArcMap 9.2 software was used to plot
school locations.
Ethical approval
E t h i c a la p p r o v a lf o rt h es u r v e yw a so b t a i n e df r o mt h e
Ministry of Health and Sanitation, Sierra Leone and the
Liverpool School of Tropical Medicine Research Ethics
Committee. Community informed consent was obtained
following discussion with District Medical Officers, Chief-
dom school inspectors, head teachers and community-tea-
chers associations. Individual verbal consent was obtained
from parents or carers as literacy rates among parents
were low in most of these locations.
Results
A total of 448 children were examined 6 months after
the MDA. There was no significant difference in the
sample size by sex: boys 227, girls 221.
Schistosoma mansoni
The overall prevalence of S. mansoni infection in school
children aged 9-14 years in these sentinel sites was 69.0%
(95% CI: 64.7-73.2%) before MDA and it was 38.2% (95%
CI: 33.8-42.8%) 6 months after MDA as shown in Table 1
and illustrated in Figure 1. This represents a significant
reduction of 44.6% in prevalence after a single dose of pra-
ziquantel (p < 0.001). The overall intensity of S. mansoni
infection was 170.8 epg (95% CI: 84.2-257.3 epg) before
MDA and it was 47.3 epg (95% CI: 11.2-83.4 epg) 6
months after MDA. This represents a significant reduction
of 72.3% from moderate to low mean intensity of infection
(p < 0.001). Most importantly, the proportion of moder-
ately and heavily infected children decreased from over
35.6% to 9.9% (Table 2).
Both prevalence and intensity of S. mansoni infection
showed noticeable reduction across the districts sur-
veyed after a single praziquantel MDA, with reduction
rate ranging from 32.8% to 62.3% and 58.8-82.2%
respectively. Among 15 sentinel schools, only four (4)
schools still showed S. mansoni prevalence of over 50%
after MDA, compared with 13 schools before MDA
(details not shown). There was no significant difference
in the of S. mansoni infection reduction by sex.
Soil-transmitted helminths
The main STHs found in the surveys were hookworms,
A. lumbricoides and T. trichiura. The overall prevalence of
hookworm infection before MDA was 41.7% (95% CI:
37.3-46.4%), and it was 14.5% (95% CI: 11.6-18.1%) 6
months after MDA as shown in Table 1 and illustrated in
Figure 1. This represents a significant reduction of 65.2%
in prevalence (p < 0.001). The overall intensity of hook-
worm infection was 71.7 epg (95% CI: 44.1-99.3 epg)
before MDA, and it was 8.7 epg (95% CI: 3.5-14.0 epg) 6
months after MDA, representing a significant reduction of
87.9% (p < 0.001). Such reduction in intensity of infection
was seen across the districts surveyed. Among 15 sentinel
schools, none of the schools showed prevalence of hook-
worm infection of over 50% after MDA, compared with 6
schools before MDA (details not shown).
As previously reported [15], the overall prevalence and
intensity of A. lumbricoides and T. trichiura infections
were low before MDA at 1.8% (95% CI: 1.0-3.5%) and
3.8% (95% CI: 2.4-5.9%) and 7.1% (95% CI: 5.2-9.8%) and
2.1% (95% CI: 1.1-3.8%) 6 months after MDA respectively.
The overall intensity of A. lumbricoides and T. trichiura
infections was 7.3 epg (95% CI: 0-15.7 epg) and 12.1 epg
(95% CI: 0-27.6) before MDA, and was 6.0 epg (95% CI: 0-
13.8 epg) and 1.2 epg (95% CI: 0-2.8 epg), respectively.
Further analysis was not performed. There was no signifi-
cant difference in the of Hookworm infection reduction by
sex.
Side effects
Despite the protocols in place of feeding children before
praziquantel treatment, as many as 30% of children in
some schools were feeling unwell following treatment,
mostly with abdominal pain, nausea, vomiting, diarrhoea
and dizziness (Turay, unpublished data). These were self
limiting or responded to the donated drugs provided with
only one case requiring an intravenous infusion and one
case of convulsion though it was not clinically confirmed
to be due to praziquantel treatment (NTDCP report).
Costs
The total additional cost of delivering MDA in 2009 was
169,010 US dollars excluding the salaries from the Minis-
try of Health and Sanitation, logistic, drug supplies and
infrastructure or 0.15 US dollars per child treated against
schistosomiasis and STH. The total cost of performing the
post MDA survey was 9,900 US dollars ($4.3 per child)
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Page 3 of 8Table 1 Prevalence and intensity of S mansoni and hookworm in children aged 9-14 years before and 6 months after praziquantel and mebendazole
administration by district and by sex
Pre-MDA Post-MDA Reduction (%)
No of children examined S.mansoni Hookworm No of Children examined S.mansoni Hookworm S.mansoni Hookworm
Prevalence (%)
Overall 515 69.0 (64.7-73.2) 41.7 (37.3-46.4) 448 38.2 (33.8-42.8) 14.5 (11.6-18.1) 44.6 65.2
By district
Bo 60 33.3 (22.7-45.9) 48.3 (36.2-60.7) 60 21.7 (13.1-33.6) 26.7 (17.1-39.0) 34.8 44.7
Kailahun 60 56.7 (44.1-68.4) 21.7 (13.1-33.6) 60 25.0 (15.8-37.2) 11.7 (5.8-22.2) 55.9 46.1
Kenema 38 73.7 (55.6-85.8) 50.0 (15.8-37.2) 29 41.4 (25.5-59.3) 10.3 (3.6-26.4) 43.8 79.4
Koinadugu 177 82.9 (75.7-88.9) 47.3 (38.8-56.4) 120 45.0 (36.4-53.9) 12.5 (7.7-19.6) 45.7 73.6
Kono 120 75.0 (66.6-81.9) 32.5 (24.8-41.3) 119 50.4 (41.8-59.3) 10.9 (6.5-17.8) 32.8 66.5
Tonkolili 60 75.0 (62.8-84.2) 58.3 (45.7-69.9) 60 28.3 (18.5-40.8) 18.3 (10.6-29.9) 62.3 68.6
By sex
Boys 262 69.4 (63.2-75.0) 50.8 (44.2-57.1) 227 40.1 (33.9-46.6) 19.4 (14.8-25.0) 42.2 61.8
Girls 252 68.9 (62.7-74.8) 32.5 (26.9-39.2) 221 36.2 (30.2-42.7) 9.5 (6.3-14.1) 47.5 70.8
Intensity of infection (epg)
Overall 515 170.8 (84.2-257.3) 71.7 (44.1-99.3) 448 47.3 (11.2-83.4) 8.7 (3.5-14.0) 72.3 87.9
By district
Bo 60 36.0 (0-114.4) 84.4 (31.8-137.0) 60 6.4 (2.8-10.0) 13.6 (4.7-22.5) 82.2 83.9
Kailahun 60 53.6 (32.2-75.0) 14.4 (0-32.2) 60 22.1 (0-44.6) 4.0 (2.2-5.8) 58.8 72.2
Kenema 38 111.8 (61.4-162.2) 79.6 (42.9-116.2) 29 31.4 (6.1-56.8) 4.1 (0-9.6) 71.9 94.8
Koinadugu 177 172.5 (133.8-211.2) 107.3 (9.9-204.7) 120 55.8 (13.2-98.4) 8.6 (0-22.0) 67.7 92.0
Kono 120 326.6 (14.3-638.9) 28.0 (21.1-34.9) 119 86.9 (0-214.2) 8.1 (0-17.9) 73.4 71.1
Tonkolili 60 137.2 (0.8-273.6) 128.4 (116.8-140.0) 60 25.6 (0-55.9) 12.4 (0-31.1) 81.3 90.3
By sex
Boys 262 165.4 (90.9-239.9) 89.5 (45.1-133.9) 227 57.1 (4.8-109.4) 14.1 (3.9-24.3) 65.5 84.2
Girls 252 177.2 (73.7-280.6) 53.5 (32.6-74.5) 221 37.2 (15.8-58.7) 3.3 (1.4-5.2) 79.0 93.8
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8Figure 1 Mapping of sites and prevalence of S mansoni and hookworm before and after MDA.
Table 2 Percentage proportions of children infected with S. mansoni before and after MDA
Intensity of infection Proportion (95% CI) before MDA (%) Proportion (95% CI) after MDA (%)
0 epg 29.5 (25.7-33.6) 56.8 (52.3-61.1)
Light 1-99 epg 35.0 (31.0-39.2) 25.2 (21.6-29.2)
Moderate 100-399 epg 24.1 (20.6-28.0) 7.8 (5.7-10.5)
Heavy ≥ 400 epg 11.5 (9.0-14.5) 2.1 (1.1-3.7)
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Page 5 of 8including the costs of surveying 504 pre-school children
aged 4-5 years old reported separately. In addition the
costs of providing drugs to treat common side effects:
paracetamol, oral rehydration salts and anti-histamines
(donated) were estimated as 3,000 US dollars.
Discussion
The national mapping data illustrated the significant bur-
den caused by S. mansoni and hookworm to school-age
children in Sierra Leone. A single round of praziquantel
and mebendazole significantly reduced prevalence and
intensity of both infections 6 months after treatment.
Overall prevalence of S. mansoni fell from high to moder-
ate and hookworm from moderate to low 6 months post
MDA. Overall intensity of S. mansoni fell from moderate
to low and hookworm intensity which was already low pre
MDA fell significantly 6 months post MDA. Importantly
the proportion of heavy infections was greatly reduced and
this would certainly contribute to the reduction of mor-
bidity, including anaemia, in school age children as shown
previously by others [26,27]. The present results on
S. mansoni from the national NTD control program in
Sierra Leone are in line with the results from other
national programs e.g. in Uganda [28,29]. According to
the national mapping surveys in 2008-09, S. haematobium
is also present in these districts (Hodges et al. unpublished
data). S. haematobium was not monitored during sentinel
site survey due to logistic reason, however, a significant
reduction in S. haematobium infection is also anticipated,
as it has been proved by others that a single praziquantel
treatment significantly reduced both prevalence and inten-
sity of S. haematobium infection in the large-scale national
control programs in Niger and Burkina Faso [30,31].
A lesson has been learnt from Swaziland where de-
worming with praziquantel caused serious political pro-
blem leading to the program suspension due to large num-
ber of children falling ill after taking the tablets [32]. In
order to avoid such problems in the national control pro-
gram in Sierra Leone, serious measures were taken to start
the treatment. However the intensive community sensiti-
sation both pre-and during implementation kept commu-
nities informed of potential side-effects and long-term
benefits of the treatment. After gaining experience from
this first MDA, the schistosomaisis control program was
scaled up to include all school-age children and at risk
adults in endemic districts in 2010. Communities under-
stood the situation and showed high compliance when the
second round of MDA was delivered. This provided an
example for other countries t os t a r tt h e i rf i r s tr o u n do f
large-scale praziquantel MDA, particularly in high ende-
micity areas.
There was a significant increase (p < 0.05) in Ascaris
prevalence between pre and post-MDA results at two
sites: Sulima in Koinadugu District (0% pre-MDA and 17%
post-MDA) and Lei, in Kono District (0% pre-MDA and
20% post-MDA). The prevalence of hookworm and T. tri-
chiura in Lei post MDA had not changed significantly:
27-23%, and 3-0% respectively. This may have been simply
due to the sampling bias in two cross-sectional surveys.
On the other hand, Sulima and Lei are both extremely
‘Hard to Reach’. These results concur with a shortage of
mebendazole supplies that were later reported by some
health staff after MDA and are reflected in the numbers of
children treated with praziquantel: 562,980 versus meben-
dazole: 549,701. Shortage of supplies cannot be easily cor-
rected during MDA due to the rough terrain in ‘Hard to
Reach’ locations and the commencement of the rainy sea-
son making transportation over roads and rivers treacher-
ous. This illustrates how extremely vulnerable children in
the ‘Hard to Reach’ areas are, still at risk of not receiving
treatment even when a successful MDA campaign such as
this achieved a reported coverage of 92% and overall satis-
factory parasitological results.
Monitoring and evaluation of the impact is a crucial
component of the national NTD control program. It is
important to monitor the progress and to fine-tune a
treatment strategy according to local changing epidemio-
logical situations [31]. This area has been relatively less
well funded within the current funding stream. Thanks to
the UNICEF support, the current sentinel site survey was
conducted and a further impact assessment survey of
school-aged children in these same sentinel sites is being
planned for pre-MDA in 2012. It is noted that in the cur-
rent survey there was a strong representation of sites with
high endemicity level (prevalence ≥ 50%). It would be use-
ful to select some sites in the moderate and low endemi-
city categories to give a better understanding of overall
progress of the national program in the future surveys.
Another limitation of the study is the diagnostic method
used. As discussed previously [16], the addition of forma-
lin as a preservative may have diluted the stool samples
and caused underestimation of the prevalence and poten-
tial overestimation of the intensity of infection. However,
the sentinel sites for this study were in remote, ‘hard to
reach’ locations where it was not possible to process and
examine the stool samples on site. Adding formalin to pre-
serve the stool samples was a necessary trade-off to avoid
disintegration of helminth eggs, particularly hookworm,
eggs. And during the preparation of the slides, care was
taken to avoid access liquid. Considering the similar
method was used both before and after MDA, such slight
misestimating would not make much difference to the
overall impact of the treatment shown here.
Conclusions
This study showed that a significant impact on S. mansoni
and hookworm infections was achieved in the first round
of MDA with high coverage rates in Sierra Leone. This
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achievement.
Acknowledgements
The pre MDA surveys and MDA was made possible with funding from the
United States Agency for International Development (USAID). USAID support
for NTD control in Sierra Leone is provided through a grant to Helen Keller
International as part of the Neglected Tropical Disease (NTD) Control
Program led by RTI International under Cooperative Agreement No. GHS-A-
00-06-00006-00. The contents are the responsibility of the authors and do
not necessarily reflect the views of USAID or the United States Government.
The post MDA survey was funded by the UNICEF. Special thanks to St
Andrews Clinics for Children-SL and H. Turay for supporting the field work.
Assistance in the stool processing was provided by I. Fofanah and M. Bah,
HKI interns and MOH&S technicians. We would also like to thank staff at the
University of Sierra Leone and Njala University, chiefs, headmasters, parents
and children who collaborated in this survey.
Author details
1Helen Keller International, PO Box 369, Freetown, Sierra Leone.
2Liverpool
School of Tropical Medicine, Liverpool, UK.
3National NTDCP, Ministry for
Health and Sanitation, Freetown, Sierra Leone.
4School of Community Health
and Clinical Sciences, Njala University, Bo, Sierra Leone.
5Helen Keller
International, Regional Office for Africa, Dakar, Senegal.
Authors’ contributions
MH conceived, designed, supervised the study, drafted and revised the
paper; MS and EN coordinated the field data collection; ND, AW, LB and JP
performed the laboratory investigation and initial data analysis. JP and MH
performed the initial data analysis. YZ conducted final data analysis and
revised the paper. All authors reviewed the paper. All authors read and
approved the final manuscript.
Competing interests
The authors declare that they have no competing interests.
Received: 15 June 2011 Accepted: 22 January 2012
Published: 22 January 2012
References
1. Bethony J, Brooker S, Albonico M, Geiger SM, Loukas A, Diemert D,
Hotez PJ: Soil-transmitted helminth infections: ascariasis, trichuriasis, and
hookworm. Lancet 2006, 367(9521):1521-1532.
2. Steinmann P, Keiser J, Bos R, Tanner M, Utzinger J: Schistosomiasis and
water resources development: systematic review, meta-analysis, and
estimates of people at risk. Lancet Infect Dis 2006, 6(7):411-425.
3. Hotez PJ, Molyneux DH, Fenwick A, Kumaresan J, Sachs SE, Sachs JD,
Savioli L: Control of neglected tropical diseases. N Engl J Med 2007,
357(10):1018-1027.
4. Hotez P, Gupta R, Mahoney R, Poste G: Incorporating appropriate
technology into North American schools of public health. Rev Panam
Salud Publica 2006, 19(2):118-123.
5. Hotez PJ, Brindley PJ, Bethony JM, King CH, Pearce EJ, Jacobson J:
Helminth infections: the great neglected tropical diseases. J Clin Invest
2008, 118(4):1311-1321.
6. King CH, Dickman K, Tisch DJ: Reassessment of the cost of chronic
helmintic infection: a meta-analysis of disability-related outcomes in
endemic schistosomiasis. Lancet 2005, 365(9470):1561-1569.
7. Savioli L, Albonico M, Engels D, Montresor A: Progress in the prevention
and control of schistosomiasis and soil-transmitted helminthiasis.
Parasitol Int 2004, 53(2):103-113.
8. Crompton DW, Nesheim MC: Nutritional impact of intestinal helminthiasis
during the human life cycle. Annu Rev Nutr 2002, 22:35-59.
9. Guyatt H: Do intestinal nematodes affect productivity in adulthood?
Parasitol Today 2000, 16(4):153-158.
10. Brooker S, Clements AC, Bundy DA: Global epidemiology, ecology and
control of soil-transmitted helminth infections. Adv Parasitol 2006,
62:221-261.
11. Atlas of global distribution of schistosomiasis. [http://www.who.int/
wormcontrol/documents/maps/country/en/].
12. White PT, Gbakima AA, Amara SV: Schistosoma manson in Sierra Leone: an
invader extending its range? Ann Trop Med Parasitol 1989, 83(2):191-193.
13. Onabamiro SD: Studies in schistosomiasis in Sierra Leone. II. Seasonal
fluctuation in the population density of Bulinus (Physopsis) globosu and
Bulinus forskali in a schistosomiasis endemic town in Sierra Leone. Ann
Trop Med Parasitol 1972, 66(3):375-383.
14. Onabamiro SD: Studies on schistosomiasis in Sierra Leone. I Ann Trop Med
Parasitol 1971, 65(4):497-504.
15. Koroma JB, Peterson J, Gbakima AA, Nylander FE, Sahr F, Soares
Magalhaes RJ, Zhang Y, Hodges MH: Geographical distribution of
intestinal schistosomiasis and soil-transmitted helminthiasis and
preventive chemotherapy strategies in sierra leone. PLoS Negl Trop Dis
2010, 4(11):e891.
16. Hodges M, Dada N, Wamsley A, Paye J, Nyorkor E, Sonnie M, Barnish G,
Bockarie M, Zhang Y: Improved mapping strategy to better inform policy
on the control of schistosomiasis and soil-transmitted helminthiasis in
Sierra Leone. Parasit Vectors 2011, 4(1):97.
17. Williams RA, Koroma MM, Hodges M: Comparison of albendazole and
levamisole chemotherapy on prevalence and intensity of common soil-
transmitted helminth infections in school children, Sierra Leone. West Afr
J Med 1997, 16(3):179-183.
18. Koroma MM, Williams RA, de la Haye RR, Hodges M: Effects of albendazole on
growth of primary school children and the prevalence and intensity of soil-
transmitted helminths in Sierra Leone. JT r o pP e d i a t r1996, 42(6):371-372.
19. Bayoh MN, Hodges M: Soil-transmitted helminth infections in three
isolated communities in Sierra Leone. J Sierra Leone Med Dental
Association 1994, 8:1-7.
20. Bayoh MN, Hodges M: Effect of levamisole chemotherapy on
geohelminthiases in Sierra Leone. J Sierra Leone Med Dental Association
1993, 6:1-4.
21. Gbakima AA, Sherpard M, White PT: Intestinal helminth infections in rural
school children in Njala, Sierra Leone. East Afr Med J 1994, 71(12):792-796.
22. Gbakima AA: Intestinal parasitic infections and swamp development in
Sierra Leone. Afr J Health Sci 1994, 1(4):175-178.
23. Hodges M, Koroma JB, Sonnie M, Kennedy N, Cotter E, MacArthur C:
Neglected tropical disease control in post-war Sierra Leone. Int Health
2011, 3:69-74.
24. WHO: Prevention and control of schistosomiasis and soil-transmitted
helminthiasis. WHO Techn Rep Ser 2002, 912:p32-33.
25. Newcombe RG: Two-sided confidence intervals for the single proportion:
comparison of seven methods. Stat Med 1998, 17(8):857-872.
26. Koukounari A, Fenwick A, Whawell S, Kabatereine NB, Kazibwe F,
Tukahebwa EM, Stothard JR, Donnelly CA, Webster JP: Morbidity indicators
of Schistosoma manson: relationship between infection and anemia in
Ugandan schoolchildren before and after praziquantel and albendazole
chemotherapy. Am J Trop Med Hyg 2006, 75(2):278-286.
27. Koukounari A, Gabrielli AF, Toure S, Bosque-Oliva E, Zhang Y, Sellin B,
Donnelly CA, Fenwick A, Webster JP: Schistosoma haematobiu infection
and morbidity before and after large-scale administration of
praziquantel in Burkina Faso. J Infect Dis 2007, 196(5):659-669.
28. Kabatereine NB, Brooker S, Koukounari A, Kazibwe F, Tukahebwa EM,
Fleming FM, Zhang Y, Webster JP, Stothard JR, Fenwick A: Impact of a
national helminth control programme on infection and morbidity in
Ugandan schoolchildren. Bull World Health Organ 2007, 85(2):91-99.
29. Zhang Y, Koukounari A, Kabatereine N, Fleming F, Kazibwe F, Tukahebwa E,
Stothard JR, Webster JP, Fenwick A: Parasitological impact of 2-year
preventive chemotherapy on schistosomiasis and soil-transmitted
helminthiasis in Uganda. BMC Med 2007, 5:27.
30. Tohon ZB, Mainassara HB, Garba A, Mahamane AE, Bosque-Oliva E,
Ibrahim ML, Duchemin JB, Chanteau S, Boisier P: Controlling
schistosomiasis: significant decrease of anaemia prevalence one year
after a single dose of praziquantel in Nigerian schoolchildren. PLoS Negl
Trop Dis 2008, 2(5):e241.
31. Toure S, Zhang Y, Bosque-Oliva E, Ky C, Ouedraogo A, Koukounari A,
Gabrielli AF, Bertrand S, Webster JP, Fenwick A: Two-year impact of single
praziquantel treatment on infection in the national control programme
on schistosomiasis in Burkina Faso. Bull World Health Organ 2008,
86(10):780-787 A.
Hodges et al. BMC Infectious Diseases 2012, 12:16
http://www.biomedcentral.com/1471-2334/12/16
Page 7 of 832. Shaw C, Su Z: Prime Minister suspends exercise as ministers clash. Swazi
Times 2009.
Pre-publication history
The pre-publication history for this paper can be accessed here:
http://www.biomedcentral.com/1471-2334/12/16/prepub
doi:10.1186/1471-2334-12-16
Cite this article as: Hodges et al.: Mass drug administration significantly
reduces infection of Schistosoma mansoni and hookworm in school
children in the national control program in Sierra Leone. BMC Infectious
Diseases 2012 12:16.
Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
Hodges et al. BMC Infectious Diseases 2012, 12:16
http://www.biomedcentral.com/1471-2334/12/16
Page 8 of 8